Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes.

Sutton, Jon M; Clark, David E; Dunsdon, Stephen J; Fenton, Garry; Fillmore, Amanda; Harris, Neil V; Higgs, Chris; Hurley, Chris A; Krintel, Sussie L; MacKenzie, Robert E; Duttaroy, Alokesh; Gangl, Eric; Maniara, Wiesia; Sedrani, Richard; Namoto, Kenji; Ostermann, Nils; Gerhartz, Bernd; Sirockin, Finton; Trappe, Jörg; Hassiepen, Ulrich; Baeschlin, Daniel K

Sutton, Jon M; Clark, David E; Dunsdon, Stephen J; Fenton, Garry; Fillmore, Amanda; Harris, Neil V; Higgs, Chris; Hurley, Chris A; Krintel, Sussie L; MacKenzie, Robert E; Duttaroy, Alokesh; Gangl, Eric; Maniara, Wiesia; Sedrani, Richard; Namoto, Kenji; Ostermann, Nils; Gerhartz, Bernd; Sirockin, Finton; Trappe, Jörg; Hassiepen, Ulrich; Baeschlin, Daniel K.

Affiliation

Sutton JM; Argenta Discovery 2009 Ltd, Harlow CM19 5TR, UK. jon.sutton@glpg.com

Bioorg Med Chem Lett ; 22(3): 1464-8, 2012 Feb 01.

Article in En | MEDLINE | ID: mdl-22177783

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors Limits: Animals / Humans / Male Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2012 Document type: Article Affiliation country: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google